Quipt Home Medical (QIPT.V) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Quipt Home Medical (QIPT.V)

7.28

+0.23 (3.26%)

as of Jun 20, 2023, 7:59:56 pm Market Open.

75 watching

Investor Insights

Jul 5, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Quipt Home Medical, represented by the ticker QIPT-X, has garnered mixed reviews from experts. One reviewer indicates a past ownership experience but notes that the excitement surrounding this type of investment has diminished since the COVID-19 pandemic. The general sentiment amongst investors suggests that interest in QIPT has waned in recent years, leading to reduced trading activity. However, there is speculation that QIPT is exploring acquisition opportunities, with expectations that it may attract the attention of potential buyers in the near future. This situation implies a critical juncture for QIPT, as it navigates a challenging market environment while considering strategic options that could enhance its value to investors.

Consensus

Neutral

Valuation

Undervalued

Similar

FCX

PAST TOP PICK

(A Top Pick Sep 02/21, Down 19%) It deals in home care products, e.g. oxygen, etc. It has been growing the business by 30% over the year but the stock price is down because it is a small cap company. A different market moves them substantially higher. A recent banking deal allows for more acquisitions. It is moving from a regional player to a national one. Next year a lot of catalysts could move it higher.

WATCH

It is a Canadian company operating in just the U.S. The CEO has done a good job growing the business. It screens cheaply but needs more consistent profitability.

PAST TOP PICK

(A Top Pick Sep 02/21, Down 30%) Health care is moving into homes so it is in a good spot. It is still making accretive acquisitions and guiding 30% higher revenue. It is in 19 states. He continues to hold the debentures.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues have grown 41% since 2020 at $102M for 2021. 10% organic growth. Operational metrics are impressive that sets up the company well for future recurring revenues. Still some runway left, trading at 22x earnings. The balance sheet is healthy with net cash. Unlock Premium - Try 5i Free

TOP PICK

Home healthcare business with chronically ill patients. Growing organically at 10% per year. They are also acquiring companies and just announced 2 acquisitions. Fantastic margin at 22% EBITDA. The stock trades at 6x next year's EBITDA compared to 10x for their peers. Buying more right now. Will go higher as it gets rerated. (Analysts’ price target is $12.23)

TOP PICK

Chronic care, ventilators. Revenue growing at a fantastic rate, using a subscription model. Cheap compared to peers. Not a concern whether Medicare or Medicaid are cut. Perfect example of money rotation to small caps. Management owns a fairly good position. No dividend. (Analysts’ price target is $121.37)

PAST TOP PICK

(A Top Pick Jul 02/20, Up 72%) A US medical device company (lifts, oxyegen and other homecare products). Continues to like it, given aging demographics. The valuation is attractive. They continue to grow by acqusition, adding geographic regions and fragmented, small busineses. They have cash to buy more companies and are EBIDTA positive. Good cash flow. Expects this to get taken out one day. Price pressures are always a possibility if suppliers raise prices. Also there are reimbursement cuts in the U.S. medical system every few years, another caveat.

Showing 16 to 22 of 22 entries

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Kevin Simpson

Capital Wealth Planning

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephanie Link, Chief investment strategist, Hightower

Hightower

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Quipt Home Medical (QIPT.V)